|
Breaking
Barriers
Lack of standards and control parametres act as barrier to
the acceptance of ayurveda the world over. But the scene is
about to change as Indian players gear up to adhere to the
strict international norms and regulations. Sapna Dogra ascertains
the current status of this industry
Upfront
Novavax,
Bharat Biotech to develop flu vaccine
Specialty biotechnology company, Novavax, and privately held
Bharat Biotech International, said they had formed an alliance
to develop a pandemic influenza vaccine for India and South
Asian markets.
Hikal
receives certificate of suitability
Hikal, the long-term outsourcing partner for leading global
life sciences companies, has received the certificate of suitability
(CoS) from the European Directorate for the Quality of Medicines
(EDQM) for one of its product—’Ondansetron Hydrochloride
Dihydrate’, following the evaluation of the dossier.
Dr
Reddy’s and Argenta Discovery Announce R&D Collaboration
Dr Reddy’s Laboratories and Argenta Discovery announced
that they have entered into an agreement for the joint development
and commercialisation of a novel approach to the treatment
of Chronic Obstructive Pulmonary Disease (“COPD”).
Zydus
Cadila receives tentative approval for Carvedilol Tablets
Zydus Cadila has received tentative approval from the USFDA
to market Carvedilol Tablets 3.125 mg, 6.25 mg, 12.5 mg and
25 mg, for the US market.
Zydus
Cadila to acquire Nutralite
Strengthening its presence in the healthy dietary supplement
segment, Zydus Cadila has acquired a 14.9 percent stake in
Carnation Nutra-Analogue Foods, the manufacturers of Nutralite,
branded margarine that currently enjoys a market share close
to 60 percent.
DNL
and NCL sign MoU
Deepak Nitrite Limited (DNL) and the National Chemical Laboratory
(NCL), Pune, have entered into a Memorandum of Understanding
(MoU) that will allow DNL and NCL to work closely together
in identifying and pursuing research and development opportunities
of mutual interest.
The
Carlyle Group Invests $20 million into Claris Lifesciences
Global private equity firm, The Carlyle Group, has made a
$20 million investment in Claris Lifesciences Limited (Claris),
a leading Indian pharmaceutical company that manufactures
and markets life saving products for treating critical illness.
Stock
Watch
Drug
authority on anvil
The Ministry of Health has initiated a cross dialogue process
with the USFDA to make clinical trials in the country gain
more currency internationally.
Patent
Problems
The WTO agreement brought with it new patent laws and corresponding
expectations. If the industry has to adhere to new regulations
it requires infrastructural support from the government authorities.
Unfortunately the much called for over-haul of infrastructure
and attitude of the patent offices hasn't come in sync with
the regulations. Dr Rajendran, Head Knowledge Cell,
USV, recently wrote this letter to the patent authorities,
but is still awaiting response
|
